MedPath

Salbux Plus

Brand Name: Salbux Plus

Generic Name: Salbutamol (as sulfate) + Bromghexine Hydrochloride + Guaifenesin

Active
Registration Number

DR-XY44937

Dosage Form

Syrup

Issuance Date

July 31, 2023

Expiry Date

December 10, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1mg/2mg/50mg per 5mL
PackagingAmber PET Bottle x 100mL with 10mL measuring cup (Box of 1's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
BRONCHODILATOR / MUCOLYTIC / EXPECTORANT
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (3)

Complete list of active ingredients in this pharmaceutical product.

Salbutamol (as sulfate)Active
Bromghexine HydrochlorideActive
Monograph: bromghexine hydrochloride
GuaifenesinActive
Monograph: Guaifenesin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform